知搜-全球专利检索

  1. Login
  2. Sign Up

Search Results

7 records (took 0.01 seconds)

    TRIAZINE DERIVATIVES AS DIFFERENTIATION CATALYSTS
    2.
    发明申请
    TRIAZINE DERIVATIVES AS DIFFERENTIATION CATALYSTS 有权
    三嗪衍生物作为差异催化剂

    公开(公告)号：US20140234965A1

    公开(公告)日：2014-08-21

    申请号：US14346328

    申请日：2012-09-21

    Applicant: Marko Mihovilovic ,  Michael Schnuerch ,  Karlheinz Hilber ,  Xaver Koenig ,  Thomas Linder ,  Agnes Mike

    Inventor： Marko Mihovilovic ,  Michael Schnuerch ,  Karlheinz Hilber ,  Xaver Koenig ,  Thomas Linder ,  Agnes Mike

    IPC: C12N5/077

    CPC classification number: C12N5/0657 ,  C07D251/44 ,  C07D251/46 ,  C07D251/48 ,  C07D251/50 ,  C12N2501/999 ,  C12N2506/30

    Abstract: A method of inducing differentiation of mammalian cells into cardiomyocyte-like cells by contacting the mammalian cell with a triazine compound of formula (I), wherein X is independently —NR4— or —O—, R4 is hydrogen or C1-6-alkyl; R1 is hydroxy, C1-6-alkyl, C1-6-alkoxy, carboxy, C1-6-alkoxycarbonyl, halo, cyano, nitro, formyl, amino, C1-6-alkylamino, or di-C1-6-alkylamino, the C1-6-alkyl or -alkoxy residue being optionally substituted with one or more R5 substituents selected from hydroxy, halo, cyano, and nitro; n is 0 to 5; R2 is hydrogen, aryl, heteroaryl, or C1-6-alkyl, the aryl or heteroaryl residue being optionally substituted with one or more R1 substituents, and where the C1-6-alkyl is optionally further substituted with one or more R5 substituents; and R3 is selected from hydrogen, halo, NR4R7, OR7, SR7, and R7, where the same options apply for R7 as for R2; with the proviso that the compound of formula (I) is not 3-[(4,6-diphenoxy-1,3,5-triazin-2-yl)amino]benzoic acid.

    Abstract translation: 通过使哺乳动物细胞与式（I）的三嗪化合物接触，诱导哺乳动物细胞分化为心肌细胞样细胞的方法，其中X独立地是-NR 4 - 或-O-，R 4是氢或C 1-6 - 烷基; R 1是羟基，C 1-6 - 烷基，C 1-6 - 烷氧基，羧基，C 1-6 - 烷氧基羰基，卤素，氰基，硝基，甲酰基，氨基，C 1-6 - 烷基氨基或二-C 1-6 - 烷基氨基 C 1-6 - 烷基或烷氧基残基任选被一个或多个选自羟基，卤素，氰基和硝基的R 5取代基取代; n为0〜5; R 2是氢，芳基，杂芳基或C 1-6 - 烷基，芳基或杂芳基残基任选地被一个或多个R 1取代基取代，并且其中C 1-6 - 烷基任选进一步被一个或多个R 5取代基取代; 并且R 3选自氢，卤素，NR 4 R 7，OR 7，SR 7和R 7，其中与R 2相同的选择适用于R 2; 条件是式（I）化合物不是3 - [（4,6-二苯氧基-1,3,5-三嗪-2-基）氨基]苯甲酸。

    Substituted pyridines and pyrimidines
    5.
    发明授权
    Substituted pyridines and pyrimidines 有权
    取代的吡啶和嘧啶

    公开(公告)号：US08986994B2

    公开(公告)日：2015-03-24

    申请号：US13519690

    申请日：2010-12-28

    Applicant: Marko Mihovilovic ,  Michael Schnuerch ,  Moumita Koley ,  Karlheinz Hilber ,  Xaver Koenig

    Inventor： Marko Mihovilovic ,  Michael Schnuerch ,  Moumita Koley ,  Karlheinz Hilber ,  Xaver Koenig

    IPC: C12N5/071 ,  C07D239/48 ,  C07D213/74 ,  C12N5/077

    CPC classification number: C07D239/48 ,  C07D213/74 ,  C12N5/0657 ,  C12N2500/40

    Abstract: Provided are compounds of formula (I) and/or salts thereof, of the class of substituted pyridines and pyrimidines, useful for inducing cardiomyogenesis, a process for producing cardiomyocyte-like cells from mammalian cells by culturing mammalian cells in the presence of the compound of formula (I), the pharmaceutical use of compounds of formula (I) for producing cardiomyocyte-like cells from omnipotent, pluripotent, or lineage committed mammalian cells, and the use of thus produced cardiomyocyte-like cells for treating disorders associated with impaired function of the heart.

    Abstract translation: 本发明提供了可用于诱导心肌发生的取代的吡啶类和嘧啶类的式（I）和/或其盐的化合物，通过在哺乳动物细胞中存在下培养哺乳动物细胞从哺乳动物细胞中产生心肌细胞样细胞的方法 式（I），式（I）化合物用于从全能，多能性或谱系确定的哺乳动物细胞产生心肌细胞样细胞的药物用途，以及由此产生的心肌细胞样细胞用于治疗与功能障碍相关的疾病 心脏

Patent Agency Ranking